Introduction
The development of a cure
for mankind
Develop a cure for humanity.
Introduction
The development of
a cure for mankind
Develop a cure for humanity.
akrocell Biosciences, Inc.
Established in April 2021, Akrocell Biosciences is dedicated to researching and developing
tissue regenerative therapeutics to provide new, healthy lives to patients suffering from
organ and tissue damage.
akrocell Biosciences
Established in April 2021, Akrocell Biosciences is dedicated to researching and developing tissue regenerative therapeutics to provide new, healthy lives to patients suffering from organ and tissue damage.
For over 30 years, tissue engineering has focused on helping patients who need organ and tissue transplants; however, the commercialization of a breakthrough technology that can resolve the extreme shortage of organs
or tissues has yet to be realized.
Our goal is to develop RMAT (Regenerative Medicine Advanced Therapy) products that will solve these market problems by collaborating with experts and executives in the field.
For over 30 years, tissue engineering has focused on helping patients who need organ and tissue transplants; however, the commercialization of a breakthrough technology that can resolve the extreme shortage of organs or tissues has yet to be realized.
Our goal is to develop RMAT
(Regenerative Medicine Advanced Therapy)
products that will solve these market problems
by collaborating with experts and executives in the field.
We plan to achieve this goal through various means, including but not limited to using our proprietary technology to develop tissue regenerative therapeutics, produce biological tissue structures that function like human tissues and create artificial organs by using large organoids and other tissue engineering-related technologies.
We plan to achieve this goal through various means, including but not limited to using our proprietary technology to develop tissue regenerative therapeutics, produce biological tissue structures that function like human tissues and create artificial organs
by using large organoids and other tissue engineering-related technologies.
Our main objective is to address problems that still need to be solved to develop new therapies that will improve the lives and well-being of patients.
Our main objective is to address problems that still need to be solved
to develop new therapies that will improve the lives and well-being of patients.
CI & Vision
Akrocell Biosciences intends to grow into a leading biotech in the field of regenerative medicine
including Cell & Gene Therapy, new treatment trends that will lead the new era.
Akrocell Biosciences intends to grow into a leading biotech in the field of regenerative medicine
including Cell & Gene Therapy, new treatment trends that will lead the new era.
Mission
Developing Tissue Regenerative Therapeutics enabling to provide
new life opportunities to patients suffering from organ/tissue failure
Mission
Developing Tissue Regenerative Therapeutics enabling to provide new life opportunities to patients suffering from organ/tissue failure
Core Values
Responsibility
Knowledge-based
Mutual Respect
Authenticity & Integrity
Responsibility
Knowledge-based
Mutual Respect
Authenticity & Integrity
akrocell Biosciences, Inc.
CEO : Mr. Andy Byungho Song
Business Registration Number : 340-86-02064
Address : 3F, Open Innovation Bldg., Seoul Biohub, 117-3, Hoegi-ro, Dongdaemun-gu, Seoul 02445, Republic of Korea
TEL : +82 (0)2-2135-3730 ㅣ FAX : +82 (0)70-4369-5154
COPYRIGHT akrocell Biosciences, Inc ALL RIGHT RESERVED.
akrocell Biosciences, Inc. ㅣ CEO : Mr. Andy Byungho Song ㅣ Business Registration Number : 340-86-02064
Address : 3F, Open Innovation Bldg., Seoul Biohub, 117-3, Hoegi-ro, Dongdaemun-gu, Seoul 02445, Republic of Korea
TEL : +82 (0)2-2135-3730 ㅣ FAX : +82 (0)70-4369-5154
COPYRIGHT akrocell Biosciences, Inc. ALL RIGHT RESERVED.
